Hemopoietic stem cell transplantation in thalassemia

a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000–2010

Donatella Baronciani, E. Angelucci, Ulrike Pötschger, J. Gaziev, Akif Yesilipek, Marco Zecca, Maria Grazia Orofino, Claudio Giardini, A. Al-Ahmari, Sara Marktel, J. de la Fuente, A. Ghavamzadeh, Ayad Achmed Hussein, Clara Targhetta, F. Pilo, Franco Locatelli, G. Dini, P. Bader, Christina Peters

Research output: Contribution to journalArticle

Abstract

Allogeneic hemopoietic stem cell transplantation (HSCT) is the only method currently available to cure transfusion-dependent thalassemia major that has been widely used worldwide. To verify transplantation distribution, demography, activity, policies and outcomes inside the European Group for Blood and Marrow Transplantation (EBMT), we performed a retrospective non-interventional study, extracting data from the EBMT hemoglobinopathy prospective registry database. We included 1493 consecutive patients with thalassemia major transplanted between 1 January 2000 and 31 December 2010. In total, 1359 (91%) transplants were performed on patients

Original languageEnglish
JournalBone Marrow Transplantation
DOIs
Publication statusAccepted/In press - Jan 11 2016

Fingerprint

Hemoglobinopathies
Thalassemia
beta-Thalassemia
Stem Cell Transplantation
Bone Marrow Transplantation
Registries
Transplantation
Blood Group Antigens
Bone Marrow
Demography
Databases
Transplants

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Hemopoietic stem cell transplantation in thalassemia : a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000–2010. / Baronciani, Donatella; Angelucci, E.; Pötschger, Ulrike; Gaziev, J.; Yesilipek, Akif; Zecca, Marco; Orofino, Maria Grazia; Giardini, Claudio; Al-Ahmari, A.; Marktel, Sara; de la Fuente, J.; Ghavamzadeh, A.; Hussein, Ayad Achmed; Targhetta, Clara; Pilo, F.; Locatelli, Franco; Dini, G.; Bader, P.; Peters, Christina.

In: Bone Marrow Transplantation, 11.01.2016.

Research output: Contribution to journalArticle

Baronciani, D, Angelucci, E, Pötschger, U, Gaziev, J, Yesilipek, A, Zecca, M, Orofino, MG, Giardini, C, Al-Ahmari, A, Marktel, S, de la Fuente, J, Ghavamzadeh, A, Hussein, AA, Targhetta, C, Pilo, F, Locatelli, F, Dini, G, Bader, P & Peters, C 2016, 'Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000–2010', Bone Marrow Transplantation. https://doi.org/10.1038/bmt.2015.293
Baronciani, Donatella ; Angelucci, E. ; Pötschger, Ulrike ; Gaziev, J. ; Yesilipek, Akif ; Zecca, Marco ; Orofino, Maria Grazia ; Giardini, Claudio ; Al-Ahmari, A. ; Marktel, Sara ; de la Fuente, J. ; Ghavamzadeh, A. ; Hussein, Ayad Achmed ; Targhetta, Clara ; Pilo, F. ; Locatelli, Franco ; Dini, G. ; Bader, P. ; Peters, Christina. / Hemopoietic stem cell transplantation in thalassemia : a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000–2010. In: Bone Marrow Transplantation. 2016.
@article{99638d24056941d5987c786a52524849,
title = "Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000–2010",
abstract = "Allogeneic hemopoietic stem cell transplantation (HSCT) is the only method currently available to cure transfusion-dependent thalassemia major that has been widely used worldwide. To verify transplantation distribution, demography, activity, policies and outcomes inside the European Group for Blood and Marrow Transplantation (EBMT), we performed a retrospective non-interventional study, extracting data from the EBMT hemoglobinopathy prospective registry database. We included 1493 consecutive patients with thalassemia major transplanted between 1 January 2000 and 31 December 2010. In total, 1359 (91{\%}) transplants were performed on patients",
author = "Donatella Baronciani and E. Angelucci and Ulrike P{\"o}tschger and J. Gaziev and Akif Yesilipek and Marco Zecca and Orofino, {Maria Grazia} and Claudio Giardini and A. Al-Ahmari and Sara Marktel and {de la Fuente}, J. and A. Ghavamzadeh and Hussein, {Ayad Achmed} and Clara Targhetta and F. Pilo and Franco Locatelli and G. Dini and P. Bader and Christina Peters",
year = "2016",
month = "1",
day = "11",
doi = "10.1038/bmt.2015.293",
language = "English",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Hemopoietic stem cell transplantation in thalassemia

T2 - a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000–2010

AU - Baronciani, Donatella

AU - Angelucci, E.

AU - Pötschger, Ulrike

AU - Gaziev, J.

AU - Yesilipek, Akif

AU - Zecca, Marco

AU - Orofino, Maria Grazia

AU - Giardini, Claudio

AU - Al-Ahmari, A.

AU - Marktel, Sara

AU - de la Fuente, J.

AU - Ghavamzadeh, A.

AU - Hussein, Ayad Achmed

AU - Targhetta, Clara

AU - Pilo, F.

AU - Locatelli, Franco

AU - Dini, G.

AU - Bader, P.

AU - Peters, Christina

PY - 2016/1/11

Y1 - 2016/1/11

N2 - Allogeneic hemopoietic stem cell transplantation (HSCT) is the only method currently available to cure transfusion-dependent thalassemia major that has been widely used worldwide. To verify transplantation distribution, demography, activity, policies and outcomes inside the European Group for Blood and Marrow Transplantation (EBMT), we performed a retrospective non-interventional study, extracting data from the EBMT hemoglobinopathy prospective registry database. We included 1493 consecutive patients with thalassemia major transplanted between 1 January 2000 and 31 December 2010. In total, 1359 (91%) transplants were performed on patients

AB - Allogeneic hemopoietic stem cell transplantation (HSCT) is the only method currently available to cure transfusion-dependent thalassemia major that has been widely used worldwide. To verify transplantation distribution, demography, activity, policies and outcomes inside the European Group for Blood and Marrow Transplantation (EBMT), we performed a retrospective non-interventional study, extracting data from the EBMT hemoglobinopathy prospective registry database. We included 1493 consecutive patients with thalassemia major transplanted between 1 January 2000 and 31 December 2010. In total, 1359 (91%) transplants were performed on patients

UR - http://www.scopus.com/inward/record.url?scp=84954526227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954526227&partnerID=8YFLogxK

U2 - 10.1038/bmt.2015.293

DO - 10.1038/bmt.2015.293

M3 - Article

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

ER -